Ballreich J, Mansour O, Hu E, et al. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020;3(11):e2023677. doi:10.1001/jamanetworkopen.2020.23677
A decision analytic dynamic Markov model on the US population aged 12 years or older was used to project the number of fatal overdoses caused by any opioid between 2020 – 2029 and project the number of deaths that can be averted by prescribing restrictions, naloxone distribution, and expansion of MAT interventions. Based on data taken from 2010-2018 National Survey on Drug Use and Health, Centers for Disease Control and Prevention, National Health and Nutrition Examination Survey, the US Census, and the National Epidemiologic Survey on Alcohol and Related Conditions- III, the status quo, the...
UNODC has launched a new survey to collect feedback on the World Drug Report.
The objective of this survey is to maintain the relevance of the World Drug Report by understanding how it is used and the extent to which it fulfils the needs and expectations of its readers.
The deadline for submission is the 21st of September.
Shared by James Harvey
(ISSUP staff) - Mar, 19/05/2020 - 13:10
This free webinar-based training course on Motivational Interviewing (MI) is presented by Igor Koutsenok, MD, MS, Professor of Psychiatry at the University of California San Diego, Department of Psychiatry.
Motivational Interviewing is an essential, client-centered, counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence. We are absolutely thrilled to bring you this skills-building opportunity presented by a recognized expert in the field of MI.
The course consists of four sessions (originally held during June 2020).
The University of California San Diego, School of Medicine, Department of Psychiatry, is honored to award you with a full tuition scholarship to the virtual 49th Summer Clinical Institute in Addictions Studies 2020.
You will have a chance to interact and learn from the world leading experts , scientists, practitioners and policy makers in the area of Substance Use Disorders. We would like to thank the Scaife Family Foundation for their continues support of the institute, particularly scholarships for students and trainees.
The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery.
Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Provides a snapshot of the contents of drugs on the illegal market in Canada using 2018–2019 data from drug seizures, drug checking services and a drug...
Health care professionals around the world are fighting tirelessly to reduce the harm that is being caused by COVID-19.
Several public health organisations are creating and updating resources so that people can be updated on the changing situation and can use the knowledge to inform and adjust their practice.
NAADAC has brought together a selection of resources that offer both a general overview of the current climate as well as specific advice for health care professionals working in the DDR field.
Resources are grouped under the following headings:
Education plays a critical role in preventing substance abuse.
Drugs of Abuse, a DEA Resource Guide, is designed to be a reliable resource on the most commonly abused and misused drugs in the United States.
This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts.
As well as providing information on all the major drug classes, the resource guide describes the Controlled Substance Act and provides information on U.S. chemical...
Shared by James Harvey
(ISSUP staff) - Mar, 07/04/2020 - 12:55
Event Date
Location:
London
Reino Unido
Register for the next webinar in the ISSUP Expert days series:
Please join us on Friday 24th of April at 2pm (GMT) for an interview with Vivienne Evans OBE, ISSUP Board member and Chief Executive of Adfam - the UK’s national umbrella...
Shared by James Harvey
(ISSUP staff) - Mié, 18/03/2020 - 13:23
Format
Book
Published by / Citation
SAMHSA
Publication
This guide assists providers in offering treatment to women living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of initial use and specific treatment issues and strategies.
Shared by James Harvey
(ISSUP staff) - Vie, 13/03/2020 - 15:38
Format
ISSUP Webinar
Published by / Citation
ISSUP
This webinar focuses on the issue of self-care for addiction professionals and was delivered by ICUDDR Deputy Director Cary Hopkins Eyles.
Many of us are drawn to work in the field of substance use disorders due to our history, family, and personal traits, such as compassion and empathy. While these can be great assets, they can also be detrimental to us personally.
In this webinar, Cary explains how to identify healthy and unhealthy traits, how we can care for ourselves, and what authentic self-care looks like.
Cary has worked in the field of substance use disorders for 18 years. She...
Harvard Medical School and McLean Hospital are pleased to offer this intensive 2-day course which brings together some of the foremost authorities in the addiction field.
Topics will include new, evidence-based treatments, the nuances of...
Huhn AS, Hobelmann JG, Strickland JC, et al. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. JAMA Netw Open. 2020;3(2):e1920843. doi:10.1001/jamanetworkopen.2019.20843
Opioid use and Opioid Use Disorder (OUD) continues to be a significant public health concern in the United States.
Several medications for OUD (MOUDs) are now considered by the medical community to be the criterion standard in OUD recovery
While many individuals with opioid use disorder seek treatment at residential facilities to initiate long-term recovery, the availability and use of MOUDs in these facilities are unclear.
A recent cross-sectional study, published in JAMA Network, has examined whether residential addiction treatment facilities in the United States use medications for...
This Strategy focuses on achieving one overarching strategic outcome:
Building a stronger, healthier, drug-free society today and in the years to come by drastically reducing the number of Americans losing their lives to drug addiction in today’s crisis, and preparing now to dominate the drug environment of the future. This will be done by preventing initiates to drug use, providing treatment services leading to long-term recovery for those suffering from addiction, and aggressively reducing the availability of illicit drugs in America’s communities.